1. Wilms’ tumor 1 enhances Cisplatin‐resistance of advanced NSCLC
   Chen Wu et al, 2014, FEBS Letters CrossRef
2. PPAR Receptors Expressed from Vectors Containing CMV Promoter Can Enhance Self-Transcription in the Presence of Fatty Acids from CLA-Enriched Egg Yolks—A Novel Method for Studies of PPAR Ligands
   Aneta A. Koronowicz et al, 2020, Nutrition and Cancer CrossRef
3. JMJD6 orchestrates a transcriptional program in favor of endocrine resistance in ER+ breast cancer cells
   Partha Das et al, 2022, Frontiers in Endocrinology CrossRef
4. Insulin-like growth factor I regulates the expression of isoforms of Wilms' tumor 1 gene in breast cancer
   Musaffe Tuna et al, 2013, Tumori Journal CrossRef
5. Candidate Oligo Therapeutic Target, miR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4
   Meng Zhang et al, 2023, The Breast Journal CrossRef
6. Overexpression of WT1 in all molecular subtypes of breast cancer and its impact on survival: exploring oncogenic and tumor suppressor roles of distinct WT1 isoforms
   Hind Ben Haj Othmen et al, 2024, Molecular Biology Reports CrossRef
7. Engineering a single-chain variable fragment of cetuximab for CAR T-cell therapy against head and neck squamous cell carcinomas
   Corinna Haist et al, 2022, Oral Oncology CrossRef
8. Opposite regulation of estrogen receptor-α and its variant ER-α36 by the Wilms’ tumor suppressor WT1
   LIANGUO KANG et al, 2011, Oncology Letters CrossRef
9. The novel mTOR inhibitor CCI-779 (temsirolimus) induces antiproliferative effects through inhibition of mTOR in Bel-7402 liver cancer cells
   Shuyu Li et al, 2013, Cancer Cell International CrossRef
10. An Alkylphenol Mix Promotes Seminoma Derived Cell Proliferation through an ERalpha36-Mediated Mechanism
    Hussein Ajj et al, 2013, PLoS ONE CrossRef
11. Truncated WT1 Protein Isoform Expression Is Increased in MCF-7 Cells with Long-Term Estrogen Depletion
    Saavedra-Alonso Santiago et al, 2021, International Journal of Breast Cancer CrossRef